Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury

Producción científica: Articlerevisión exhaustiva

20 Citas (Scopus)
Idioma originalEnglish
Páginas (desde-hasta)1807-1808
Número de páginas2
PublicaciónNeural Regeneration Research
Volumen12
N.º11
DOI
EstadoPublished - nov 2017

Nota bibliográfica

Funding Information:
This work was funded by NIH R21NS096670 (AGR), Craig H. Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

Financiación

This work was funded by NIH R21NS096670 (AGR), Craig H. Neilsen Foundation 476719 (AGR), Kentucky Spinal Cord and Head Injury Research Trust #15-14A (PGS), Veterans Affairs Merit Review Award #I01BX003405 (PGS), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowments (AGR & PGS), NIH/NINDS 2P30NS051220.

FinanciadoresNúmero del financiador
NIH/NINDS2P30NS051220
National Institutes of Health (NIH)476719, R21NS096670
Nurses Organization of Veterans Affairs01BX003405
University of Kentucky
Kentucky Spinal Cord and Head Injury Research Trust15-14A

    ASJC Scopus subject areas

    • Developmental Neuroscience

    Huella

    Profundice en los temas de investigación de 'Targeting mitoNEET with pioglitazone for therapeutic neuroprotection after spinal cord injury'. En conjunto forman una huella única.

    Citar esto